Andries Zijlstra

Andries Zijlstra, Ph.D., and colleagues are studying a biomarker that can help predict prostate cancer recurrance. (photo by Susan Urmy)
December 5, 2013

Predictor of prostate cancer outcomes identified

Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread.

By VUMC News and Communications
June 7, 2013

Vanderbilt to host seventh international conference on tetraspanin scaffolding

By VUMC News and Communications